Janus Henderson Group’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-430,000
Closed -$4.42M – 2629
2023
Q2
$4.42M Hold
430,000
– – ﹤0.01% 895
2023
Q1
$4.36M Buy
430,000
+380,000
+760% +$3.83M ﹤0.01% 918
2022
Q4
$500K Buy
+50,000
New +$492K ﹤0.01% 1722

Janus Henderson Group's DALS Position: Q3 2023 in Review

Janus Henderson Group sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 430,000 shares — an estimated $4.42M sold.

Janus Henderson Group first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $4.42M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Janus Henderson Group reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Janus Henderson Group sold 430,000 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $4.42M.
  • Janus Henderson Group first reported a position in DA32 Life Science Tech Acquisition Corp in Q4 2022 and held it in 3 quarters.
  • Janus Henderson Group's DA32 Life Science Tech Acquisition Corp position peaked at $4.42M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Janus Henderson Group's 13F filing for Q3 2023, filed 14 Nov 2023.